Abstract A series of 3-diethylamino-2, 2-(dimethyl) propyl 5-substituted phenyl-2- furancarboxylates was prepared and found to be pharmacologically active in vitro as GI tract nonanticholinergic smooth muscle spasmolytic agents. One of the more active compounds in the series contained the 5-(4-nitrophenyl) group.
